Revaprazan Hydrochloride is a potassium-competitive acid blocker (P-CAB) used to treat acid-related gastrointestinal disorders like peptic ulcers, duodenal ulcers, and gastritis. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 5, 6-Dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1, 2, 3, 4-tetrahydroisoquinolin-2-yl)pyrimidine hydrochloride, 2-Pyrimidinamine, 4-(3, 4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5, 6-dimethyl- and monohydrochloride. Its PubChem CID is 204103.
Revaprazan hydrochloride
| CAS No | 178307-42-1 |
|---|---|
| Molecular Formula | C22H24ClFN4 |
| Molecular Weight | 398.9 g/mol |
| Synonyms | N-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)pyrimidin-2-amine;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Revaprazan Hydrochloride is a potassium-competitive acid blocker (P-CAB) used to treat acid-related gastrointestinal disorders like peptic ulcers, duodenal ulcers, and gastritis.
The listed CAS number is 178307-42-1.
The listed molecular formula is C22H24ClFN4.
The listed molecular weight is 398.9 g/mol.
N-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)pyrimidin-2-amine;hydrochloride.
The source lists 5, 6-Dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1, 2, 3, 4-tetrahydroisoquinolin-2-yl)pyrimidine hydrochloride, 2-Pyrimidinamine, 4-(3, 4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5, 6-dimethyl- and monohydrochloride.